These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38135518)

  • 1. Service Delivery Considerations for Introducing New Injectable Contraceptives Lasting 4 and 6 Months in Nigeria and Uganda: A Qualitative Study.
    Callahan RL; Burke HM; Lawton A; OlaOlorun FM; Mubiru F; Anyasi H; Wong CM; Bidashimwa D; Velarde M; Ruderman LW
    Glob Health Sci Pract; 2023 Dec; 11(6):. PubMed ID: 38135518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Men can take part": examining men's role in supporting self-injectable contraception in southern Malawi, a qualitative exploration.
    Ruderman LW; Packer C; Zingani A; Moses P; Burke HM
    Reprod Health; 2022 Aug; 19(1):174. PubMed ID: 35945601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
    Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
    Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos.
    Burke HM; Callahan RL; Lawton A; Turinayo A; Oyekenu O; Niyonsaba S; Taiwo O; Semaganda VM; Awiti A; Fratus A; Mubiru F; OlaOlorun FM
    Glob Health Sci Pract; 2023 Dec; 11(6):. PubMed ID: 38135521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda.
    Odwe G; Gray K; Kyarimpa A; Obare F; Nagendi G
    Glob Health Sci Pract; 2018 Dec; 6(4):711-722. PubMed ID: 30429201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.
    Stout A; Wood S; Barigye G; Kaboré A; Siddo D; Ndione I
    Glob Health Sci Pract; 2018 Mar; 6(1):55-72. PubMed ID: 29602866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.
    Lubis F; Fajans P; Simmons R
    Contraception; 1994 May; 49(5):527-41. PubMed ID: 8045136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda.
    McKenna K; Arcara J; Rademacher KH; Mackenzie C; Ngabo F; Munyambanza E; Wesson J; Tolley EE
    Glob Health Sci Pract; 2014 Oct; 2(4):459-71. PubMed ID: 25611479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia.
    Simmons R; Fajans P; Lubis F
    Contraception; 1994 May; 49(5):509-25. PubMed ID: 8045135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
    MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
    Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale-up of the DMPA-SC in Nigeria: Why policy matters.
    Akinyemi O; Danfakha N; Adefalu A; Easley E; Afolabi K; Latunji O
    BMC Womens Health; 2022 Dec; 22(1):535. PubMed ID: 36544189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
    Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
    Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Community-based distribution of injectable contraceptives in an African setting: community trial in Madagascar].
    Brunie A; Hoke TH; Razafindravony B
    Sante; 2011; 21(1):21-6. PubMed ID: 21550921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of triggers, ideation and motivational factors of contraceptive utilization among women and gate-keepers in Nigeria: a scoping study on the resilient and accelerated scale up of DMPA-SC in Nigeria (RASUDIN).
    Osinowo K; Ekholuenetale M; Ojomo O; Hassan A; Ladipo OA
    Contracept Reprod Med; 2020 Dec; 5(1):38. PubMed ID: 33292709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of Contraceptive Self-Injection with DMPA-SC Among Adolescents in Gulu District, Uganda.
    Cover J; Lim J; Namagembe A; Tumusiime J; Drake JK; Cox CM
    Int Perspect Sex Reprod Health; 2017 Dec; 43(4):153-162. PubMed ID: 29771679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for a potential longer-acting injectable contraceptive: perspectives from women, providers, and policy makers in Kenya and Rwanda.
    Tolley EE; McKenna K; Mackenzie C; Ngabo F; Munyambanza E; Arcara J; Rademacher KH; Lendvay A
    Glob Health Sci Pract; 2014 May; 2(2):182-94. PubMed ID: 25276576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injected contraceptives: does the investment reflect women's preferences?
    Wood SN; Magalona S; Zimmerman LA; OlaOlorun F; Omoluabi E; Akilimali P; Guiella G; Gichangi P; Anglewicz P
    BMJ Glob Health; 2022 Jul; 7(7):. PubMed ID: 35835480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.